NextGen Sciences Announces Collaboration with the Harvard Institute of Proteomics

Cambridgeshire, UK, 27th November 2007 – NextGen Sciences, a leading provider of gene-to-protein products and services, has announced the commencement of its collaboration with The Harvard Institute of Proteomics. The collaboration, which marks the start of NextGen Sciences’ Center of Excellence Program, will focus on integrating the Company’s Information Management Software (orchestratorIMS™) with Harvard’s extensive clone database in order to develop advanced automated methods for multi construct design.

NextGen Sciences’ Center of Excellence Program provides leading academic institutes with access to the Company’s proprietary automated platforms and software systems to advance the productivity and efficiency of their research initiatives. As part of the program, the institutions will work in partnership with NextGen Sciences to inform the co-development of new product and technology enhancements.

The collaboration with The Harvard Institute of Proteomics will focus on integrating Harvard’s clone database with orchestratorIMS™, widely regarded as the industry’s most flexible and functional information management system. By combining these leading data management systems, researchers at the Institute will be able to design key research projects and implement them using NextGen Sciences’ leading automated expressionworkstation™ platform.

Commenting on the project, Dr Joshua LaBaer, Director of the Harvard Institute of Proteomics, said: “Participation in this initiative, and access to NextGen Sciences’ orchestratorIMS licenses and expertise, will allow us to design and complete what would have been lengthy and challenging projects in a much shorter period of time and with greater ease. We look forward to working with NextGen Sciences on these key projects, and anticipate publishing robust, novel data.”

“We are very excited about the launch of our Center of Excellence Program and especially with a research group as distinguished as the Harvard Institute”, commented Dr Mike Pisano, CEO of NextGen Sciences. “The scientists at the Harvard Institute are at the leading edge of protein research and by providing access to our systems we will enable them to significantly advance the throughput of their research.”

- ENDS -

Contact

NextGen Sciences
Grant Cameron
t: +44 (0)1480 420970
e: grant.cameron@nextgensciences.com

College Hill
Katie Odgaard
t: +44 (0)207 866 7858
e: katie.odgaard@collegehill.com

Ben Routley
t: +44 (0)1260 296 500
e: ben.routley@collegehill.com

Notes to Editors:
About NextGen Sciences
NextGen Group PLC (LSE:NGG) offers its customers a comprehensive range of enabling technologies, services and expertise to improve their chance of success in protein science research. Working in partnership with 18 of the top 20 pharmaceutical companies, the Company’s products and services cover the gene to protein continuum. The Company has developed a wide range of leading automation platforms and integrated software systems that have been proven to enhance the productivity and efficiency of customers’ research programs. The services range from gene synthesis to protein expression scale-up and purification, protein analytical services, protein biomarker discovery and monitoring.

The breadth of services has been enhanced through key strategic partnerships with Gene Oracle, Inc., for gene optimization and synthesis, and Kemp Biotechnologies, Inc., for protein expression scale up, cell culture and protein purification.

Further details relating to NextGen Group PLC and its products can be found at www.nextgensciences.com

For information on the Harvard Institute of Proteomics, visit http://www.hip.harvard.edu/